Found 132 clinical trials
A Polypill for Secondary Prevention of Ischemic Heart Disease
Cardiovascular diseases (CVD) are the leading cause of mortality and morbidity worldwide. The most important aspect of CVD secondary prevention is adherence to guideline-indicated
- 10 views
- 26 Jan, 2021
- 2 locations
Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis
The objective of the study is to demonstrate the superiority of the mesoglycan (Prisma), compared to placebo, in reducing the incidence of thromboembolic complications (relapse / extension of superficial venous thrombosis (SVT), deep venous thrombosis (DVT), pulmonary embolism (PE)) in patients who have completed the cycle of therapy of the …
- 9 views
- 02 Mar, 2022
- 1 location
Preventing Urinary Tract Infections With E. Coli Nissle:
children. The aim of this study is to evaluate efficacy of E. coli Nissle strain in secondary prevention of urinary tract infections in young children.
- 0 views
- 30 Jan, 2021
- 5 locations
Aspirin in Colorectal Cancer Liver Metastases (ASAC)
investigators group and others have shown a potential association of ASA also taken after the diagnosis on CRC survival in registry-based studies (secondary prevention). Up to 800 patients operated for CRCLM
- 205 views
- 29 Apr, 2022
- 15 locations
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) (Jason)
; Sulodexide 500 BID in die or indistinguishable placebo to verify the efficacy and safety of extended treatment for 12 months with Sulodexide (Vessel) in the secondary prevention of Deep Vein Thrombosis
- 0 views
- 25 Feb, 2022
- 1 location
Effects of Bilberry and Oat Intake After AMI (BIOAMI)
concentrations of biochemical markers of inflammation, metabolomics and gut microbiota composition after three months. Implications Secondary prevention after AMI has
- 0 views
- 11 May, 2022
- 2 locations
Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain (PACBACK)
poor. Moreover, little is known about the role of these treatments in the secondary prevention of chronic LBP (cLBP), especially for patients with biopsychosocial risk factors. With burgeoning costs
- 631 views
- 16 Feb, 2022
- 2 locations
Aspirin to Target Arterial Events in Chronic Kidney Disease (ATTACK)
risk of bleeding. Aspirin is recommended to prevent further CVD in people who have already had a first CVD event (so called secondary prevention). Here the investigators want to study the use of
- 0 views
- 25 Mar, 2022
- 1 location
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
Design: U.S.-based, single-center, randomized placebo-controlled trial. Brief Treatment Description: Low-intensity apixaban (2.5mg twice daily) for extended-duration secondary prevention
- 0 views
- 11 Jul, 2021
- 1 location
Suicide Prevention Among Recipients of Care
Randomized controlled trial to determine the best brief suicide prevention intervention for adults and adolescents who screen positive for suicidal ideation or behavior in emergency departments or primary care clinics. Aim 1: Compare the effectiveness of two brief suicide prevention interventions (safety planning intervention plus structured phone-based follow-up from a …
- 0 views
- 03 Oct, 2021
- 1 location